Editas Medicine, Inc.
EDIT· Nasdaq
EDITEditas Medicine, Inc.
Filed Mar 8, 2018 · 10-K · 67 days after period end · 0001558370-18-001721
| Metric | Q4 2017 | Q4 2016 | Q4 2015 |
|---|---|---|---|
| Revenue | $3.67M | — | — |
| Net Income | -$36.19M | -$39.38M | -$12.63M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Editas Medicine, Inc. · CIK 1650664 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Mar 8, 2018 · 67 d after period end
